text:
Eli Mordechai, Ph.D.
Chief Executive Officer
Eli Mordechai, Ph.D., is the Founder of the privately-held Genesis Biotechnology Group headquartered in Hamilton, New Jersey. As the Chief Executive Officer, Dr. Mordechai's forward-thinking leadership inspires and empowers the ongoing discovery and development of innovative scientific products and services that fulfill important clinical needs to enhance the quality of life of patients in the United States and around the world. With visions of executing GBG's mission of delivering inventive products and services while growing steadily and competitively in the biotechnology marketplace, Dr. Mordechai continues to expand GBG with vertically-integrated business initiatives in mind. Dr. Mordechai's successes in tactically implementing vertical integration are evidenced by GBG's collection of operational platforms in laboratory sciences, clinical research, drug discovery, and manufacturing and the comprehensive services, efficiencies, and creativity these collaborative processes yield.
Dr. Mordechai oversees GBG's day-to-day operations and meets with his senior executive teams on a regular basis to ensure that all the companies of GBG maintain the highest standards of corporate excellence, accountability and transparency. Dr. Mordechai investigates and monitors trends and forecasts in the biotechnology and healthcare industries to manage risk and optimally navigate business development for each of GBG's enterprises. His focus for GBG's market expansion involves driving core organic growth, initiating new lines of business, and being an active participant in the merger and acquisition arena. Building executive management teams comprised of industry-leading experts to carry out GBG's missions and promote its corporate culture of opportunity, honesty, and unsurpassed values and professional practices is another of Dr. Mordechai's priorities as Chief Officer.
Dr. Mordechai received his Bachelors of Science degree in Biochemistry from Rider University in Lawrenceville, New Jersey, and upon graduation he was distinguished with 'The Biochemistry Departmental Award'. He went on to earn his Ph.D. in Biochemistry from the Department of Biochemistry at Temple University School of Medicine in Philadelphia. At Temple University, Dr. Mordechai was the recipient of 'The Florence Gloria Freeman Cancer Research Award'. He completed his post-doctoral studies at the Department of Neurobiology at the Barrow Neurological Institute St. Joseph's Hospital in Phoenix, Arizona. Following the completion of his post-doctoral studies, he served as the Director of Research and Development at the Immunosciences Laboratory in Beverly Hills, California.
Dr. Mordechai scientific research is documented in over 100 peer-reviewed publications and abstracts. He has presented at a vast array scientific meetings and industry conferences, and he has authored over 25 patents. Dr. Mordechai is an Associate Professor at Rowan University Graduate School of Biomedical Sciences, and he also serves as an active member on many academic and scientific boards such as, Rider University Science Advisory Board, Board of Trustee of Rider University, Chemistry/Biochemistry Advisory Board at Burlington County Community College, Dean Development Council at Rowan University (formally UMDNJ), the Scientific Advisory Board of the Hepatitis B Foundation, and the Pennsylvania Biotechnology Center.
As an accomplished scientist, business executive, and leading community figure, Eli Mordechai, Ph.D.'s body of work and stellar reputation epitomize American ingenuity and have earned him several academic, industrial and community awards, including the Ernst & Young 'Entrepreneur of the Year' award. He was voted 'Most 50 Interesting People in Mercer County', and he received the esteemed Dean Council Award from the University of Medicine and Dentistry in New Jersey. Dr. Mordechai holds a certificate as a Medical Director from the Wadsworth Center New York State Department of Health and from the American Association of Bioanalysts (AAB). His current professional memberships include the American Society of Microbiology, Association for Molecular Pathology, International Society for Infectious Diseases, and the American Association for the Advancement of Medicine.
Martin E. Adelson, Ph.D.
Chief Operating Officer
Corporate Department and Research Department
Dr. Adelson joined the GBG team in 2002. As the Chief Operating Officer, Dr. Adelson leads clinical, development, and discovery research operations in Medical Diagnostic Laboratories, L.L.C. (MDL), Venenum Biodesign, LLC, and Invivotek LLC, with his main focus concentrating on scaling and expanding the existing business infrastructure through both organic growth and corporate acquisition. In addition, Dr. Adelson implements various innovations and re-engineering initiatives, as well as leverages customized technology solutions, to re-calibrate and enhance MDL's work flow while reducing overall business costs.
Prior to his appointment to Chief Operating Officer in 2013, Dr. Adelson held positions within MDL as Director of Research & Development before becoming Vice President of MDL in 2007.
Dr. Adelson received his BS in Biology from The College of New Jersey (formerly Trenton State College) in Ewing, NJ. He earned his Ph.D. in Molecular Biology & Genetics from the Department of Molecular Biology and Genetics/Fels Institute for Molecular Biology and Cancer at Temple University School of Medicine in Philadelphia, PA. He completed his postdoctoral studies in the Department of Microbiology and Molecular Genetics at the University of Medicine and Dentistry of New Jersey. Dr. Adleson was the proud recipient of a competitive Postdoctoral Research Fellowship from the National Institutes of Health, National Lung, and Blood Institute.
Dr. Adelson has presented more than 15 presentations for scientific meetings and conferences, clients, and special events. He is the author of 60 publications and 82 abstracts including:
- Adelson ME, Feola M, Trama JP, Tilton RC, and Mordechai E. (2005). Simultaneous detection of herpes simplex virus types 1 and 2 by real-time PCR and Pyrosequencing. Journal of Clinical Virology, 33(1): 15-34. 's
Dr. Adelson is an Associate Professor at Rowan University Graduate School of Biomedical Sciences as well as a present Member of the Thomas Jefferson University Biotechnology Program Advisory Committee. He has served on the editorial boards of Diagnostic Microbiology and Infectious Disease and Journal of Clinical Microbiology. He has also served as a guest reviewer for the Journal of Clinical Microbiology, Infection & Immunity, Journal of Applied and Experimental Microbiology, Clinical and Diagnostic Microbiology, Journal of Dermatological Science, Diagnostic Microbiology and Infectious Disease, and Clinical and Vaccine Immunology. He serves as a Scientific Advisory Board member of JBS Science, Inc. at the PA Biotechnology Center and is a founding member of the New Jersey and Pennsylvania BioTech and Life Sciences Leadership Council. Dr. Adelson also holds a certificate as a Medical Director from the Wadsworth Center New York State Department of Health. His current professional memberships include the American Society of Microbiology, International Organization for Mycoplasmology, and Association for Molecular Pathology.
Ben Bandaru, Ph.D., MBA
Director of Mergers & Acquisitions
Mergers & Acquisitions Division
Ben joined the GBG team in 2015. As the Director of Mergers and Acquisitions, he provides leadership for strategy development initiatives by working closely with the CEO and strategic business units to drive all acquisitive growth initiatives for GBG and member companies from initiating to closing and on-boarding the transaction. Through collaboration with private equity and investment banks, Ben develops and structures deals, organizes and manages the buy-side, sell-side, intellectual property out-licensing, and joint venture projects to originate new businesses and develop existing relationships.
Prior to GBG, Ben was the Vice President of US Operations, Strategic Programs, and Business Development at iMEDGlobal Corporation. Additionally, Ben held a number of positions in Pfizer Inc., where he served in and led teams in Healthcare Informatics, Acquisition Collaboration and Divestitures, Global R&D, and Global Manufacturing before becoming the Product Development Lead in the Integrated Health Business Unit. During his time with Pfizer, he was the proud recipient of the Pfizer Innovation Award.
Ben received his MBA with a concentration in Strategy from Rensselaer Polytechnic Institute. He earned his Ph.D. in Biochemistry from Wayne State University. Ben also holds a certificate as a Project Management Professional (PMP) from the Project Management Institute.
Ben's list of publications includes:
- Bandaru, B., Jaishree, G., and and Bhagwat, A. S., 1996, Overproduction of DNA Cytosine Methyltransferases causes Methylation and C to T Mutations at Non-canonical sites, Journal of Biological Chemistry, Vol. 271, No. 13, Issue of March 29, pp. 7851–7859, 1996.
- Bandaru, B., Wyszynski, M., and Bhagwat, A. S., 1995, HpaII methyltransferase is mutagenic in Escherichia coli, Journal of Bacteriology, Vol. 177, No. 10, Issue of May 1995, p. 2950–2952,1995.
- Bandaru, B., 2006, Making team perform at their peak potential, SNEC-PMI, Nov 2006, p.05.
Ben's hobbies include reading, watching movies, playing tennis and Sudoku.
Joseph Donovan
Chief Financial Officer
Accounting Department
Joe joined the GBG team in 2007 as the Accounting Manager. As the Chief Financial Officer since 2011, he is responsible for the accounting and finance functions of all GBG member companies. Joe manages the Accounting Department staff as well as day-to-day operations regarding all cash balances and the maintenance of our internal financial software. He is responsible for establishing and maintaining all banking relationships including financial reporting to banks and third party investors. He provides leadership and strategy development for financial and tax initiatives and is a vital member of the Merger and Acquisition team.
Prior to joining GBG, Joe brought with him twenty years of experience in the financial side of the manufacturing, retail, and distribution industries. Joe previously held positions as Controller of Omnitester Corp as well as Assistant Controller and Credit Manager for The Camera Shop, Inc.
Joe received his BA in Accounting from St. Joseph's University in Philadelphia, PA.
Joe's hobbies include spending time with children and grandchildren and spending time at the beach and traveling.
Susan Kase
Chief Legal Officer
Legal Department
Susan joined the GBG team in 2011. As the Chief Legal Officer, Susan provides advice and leadership to the GBG family of companies to enhance its position in the fields of clinical diagnostics, drug discovery, product development, manufacturing, and distribution. In addition, Susan structures the transactions for mergers and acquisitions to assist GBG with its strategic growth initiatives in addition to managing a staff of attorneys and outside counsel to address challenges and litigation in the areas of corporate, regulatory, compliance, healthcare, intellectual property, contracts, and employment law.
Prior to her appointment to Chief Legal Officer in 2017, Susan held positions within GBG as Associate Regulatory Counsel 2011-2015, Associate General Counsel 2015-2016, and Deputy General Counsel 2016-2017.
Susan brought twenty five years of Legal experience to the GBG Team through her previous position State of New Jersey Officer of the Attorney General where she served as the Deputy Attorney General.
Susan received her BA & BS in Arts and Science from Pennsylvania State University in State College, PA. She earned her Juris Doctor from Widener University School of Law in Wilmington, DE.
Susan was proud recipient of many awards during her time in the Office of the Attorney General Awards including Excellence in Management 2009, Excellence in Investigations 2009, and Excellence in Trial Litigation 2008. Susan was also awarded with a 2014 Galaxy Award at GBG.
During her free time, Susan enjoys running, cycling, swimming, and movies. She is a Share the Music volunteer and Therapy Dog International volunteer.
Stephanie S. Thompson, MT (ASCP)
Director of Marketing
Marketing Department, Genesis Biotechnology Group
Stephanie joined the GBG team in 1999. As the Director of Marketing, she provides leadership for the Marketing Department members including the graphic design team. She is responsible for developing, implementing, and maintaining the marketing efforts and supportive collateral for new and existing product lines and services for all GBG Member companies across all lines of business. Stephanie was directly involved in the implementation and supervision of modified processes in the sales and client daily and standing supply order process which streamlined work flow while reducing overall associated business costs.
Stephanie joined Medical Diagnostic Laboratories, L.L.C. (MDL) as a Laboratory Technician in 1999 and has since held various management positions of increasing responsibility. She developed the Quality Control Department for which she became the Quality Control Manager in 2000. As the division continued to grow in both scope and size, in 2004 Stephanie became the Director of Quality Assurance & Quality Control. In 2007, she transitioned into the role of Director of Marketing. Stephanie held a dual Directorship for ten years where she also served as the Director of Administration from 2005 – 2015.
Prior to GBG, Stephanie held a position as a Professional Blood Bank Technologist in the Department of Laboratory Medicine and Transfusion Services at the University of Pennsylvania Hospital in Philadelphia, Pennsylvania.
Stephanie received a BS in Medical Technology from the University of Delaware in Newark, De. She is a board certified Medical Technologist with the American Society of Clinical Pathologists (ASCP).
Stephanie's hobbies include reading, cooking, and raising a family of three daughters with her husband in South Jersey.
Peter Winchester
Vice President of Laboratory Operations
Genesis Biotechnology Group
Pete joined the GBG team in 2000. As the Director of Laboratory Operations, he is responsible for the overall operation and administration of a College of American Pathologists (CAP) accredited laboratory including Molecular, Microbiology, Serology, and Pathology Divisions. He ensures the development of Standard Operating Procedures (SOP) and Quality Control/Quality Assurance programs. He is responsible for recruitment and employment needs of all laboratory personnel, selection and maintenance of equipment, safety aspects, QA/QC, and proficiency testing. He takes the lead on all regulatory inspections including CAP, Clinical Laboratory Improvement Act (CLIA), NJ Department of Health, NY Department of Health, and Occupational Safety and Health (OSHA) inspections. Pete serves as Quality Manager for all FDA-related projects as well as a CAP inspector for outside laboratories.
Pete joined MDL as a Laboratory Technician in 2000 and has since held various positions of increasing responsibility including Second Shift Coordinator, Third Shift Coordinator, and Laboratory Manager. In 2005 Pete was promoted to his current position of Director of Clinical Laboratory Operations.
Pete received his BS in Biology from Rutgers University in New Brunswick, NJ.
Kelly Winchester
Vice President of Laboratory Operations
Medical Diagnostic Laboratories, L.L.C.
Kelly joined the GBG team in 2004. As the Director of Quality Control, Kelly is responsible for overseeing and managing all aspects of clinical laboratory testing for accuracy including the receipt of the test requisition and specimen, accessioning, data entry, testing, and result reporting.
Kelly began her career with MDL as a Laboratory Technician in 2004. In 2005 she became a Clinical Validation Technician and transitioned into the role of Clinical Implementation/Validation Coordinator in 2007. In 2010 Kelly was promoted to Assistant Director of the QA & QC Department. She held this position until 2012 when she became Director of Quality Control.
Kelly received her BS in Biology from Shippensburg University in Shippensburg, PA.
Valerie Tharnish, MT (ASCP)
Vice President of Sales
Genesis Biotechnology Group
Valerie joined the GBG team in 2002. As the Vice President of Sales, of GBG she oversees all the directors of the specialized sales teams. She executes operational strategies to achieve business objectives. She monitors key performance indicators (KPI's), such as, revenue growth and sales costs to achieve the company's goals.
Valerie joined Medical Diagnostic Laboratories, L.L.C. (MDL) in 2002 as a Senior Sales Executive. In 2004 she was promoted to Regional Sales Manager, a position she held until becoming the National Director of Sales in 2011. In 2013, Valerie became Vice President of Sales for MDL, a position she held until 2018 when she transitioned into her current role as Vice President of Sales for GBG.
Before joining GBG, Valerie held a position in healthcare recruitment for four years with CJ Ventures as the Vice President of Sales. She was also a Sales Executive with Quest Diagnostics for nine years.
Valerie received her BS in Biology from New College in Sarasota, Fl and her certificate in Medical Technology from the Sarasota Technical Institute. She is a board certified Medical Technologist with the American Society of Clinical Pathologists (ASCP).
Stephanie Berry, SHRM
Director of Human Resources
Human Resources Department, Genesis Biotechnology Group
Stephanie joined the GBG team in 2016 as the Human Resources Manager. As the Director of Human Resources since 2017, she provides leadership to the HR Team and oversees benefits and compensation, wellness programs, talent acquisition and employee retention, employee recognition programs, performance management, training and development, compliance, leave administration, employee relations and event planning. Stephanie is a thought-partner with the Executive Management Team and provides consultation on strategic staffing plans, compensation, benefits, training and development, budget, and labor relations. Stephanie has implemented various innovations to replace the current HRIS and revamp the benefits program to attract and retain top talent. She provides on-boarding and HR support for new acquisitions and leads Human Resources initiatives for GBG and all member companies.
Prior to GBG, Stephanie held positions in Human Resources at State of NJ – NJ Housing and Mortgage Finance Agency as an HR Generalist as well as Adelphi Group and BluePrint Research Group as HR Manager. Stephanie brought to the GBG team over 15 years of HR experience in the Pharmaceutical and Mortgage and Finance Industries.
Stephanie received her BS in Business Administration/Management from University of Reading. Stephanie holds a certificate as a Professional in Human Resource (PHR) from Villanova University in Villanova, PA, as well as a Society for Human Resource Management – Senior Professional in Human Resources (SPHR).
Stephanie is an active member of the Society for Human Resource Management (SHRM). She was the proud recipient of a Congressional Award presented by Congressman Chris Smith in recognition of her work in foster care.
Stephanie enjoys spending time with her husband and children and their many activities, traveling and giving back their community. Stephanie and her husband are advocates for children in foster care and have fostered over 25 children in their effort to adopt.
Elka Devash
President, Principal
Sherute, Genesis Investment Properties, LLC.
Elka joined the GBG team in 1999. As the President of Sherute, LLC., she is directly involved in Sherute's day-to-day operations. She is responsible for the strategic planning, designing, and implementation of decor and furnishings of all GBG member companies and properties encompassing an estimated 400,000 square feet of administrative offices, conference rooms, clinical laboratories, hospitality and residential spaces. She provides leadership to all teams within Sherute including construction, facilities maintenance and environmental services, as well as landscape design and snow removal. Elka provides guidance to the GBG web development team regarding the design aspects of all GBG company websites.
Elka began her career with Medical Diagnostic Laboratories, L.L.C. (MDL) in the clinical Laboratory in 1999 orchestrating and supervising laboratory accessioning. In 2007 she founded Sherute, LLC., and has since served as President. Elka is also currently a principal of Genesis Investment Properties, LLC.
Elka is a graduate of Vizo Technical School in Tel Aviv, Israel. Her extensive international travels and subsequent exposure to various world cultures can be seen in the global influence of her designs.
Elka is the proud mother of three and grandmother to one beautiful little girl. Her hobbies include traveling, a love of plants, and baking for family and friends.
Michael Gale
Vice President of Acquisition & Business Development
Genesis Investment Properties
Michael joined the GBG team in 2004. As the Vice President of Acquisitions & Business Development, he directs national acquisitions, dispositions, and leasing programs in support of corporate real estate investment goals. He also oversees the development of commercial and mixed-use properties as well as the property management activities for the Corporate real estate portfolio.
Michael initially joined Medical Diagnostic Laboratories, L.L.C. (MDL) in 2004 as the Operations Manager, a position he held until becoming the Director of Operations one year later. In 2007, he transitioned into the role of Director of Operations for Sherute, LLC., a position he held until 2009 when he was appointed Vice President of Operations. In 2010, Michael assumed his current position with Genesis Investment Properties as the Vice President of Acquisitions & Business Development.
Before joining GBG, Michael held a position with Congoleum Corporation as Manager of Administrative Services.
Michael received his BS in Business Administration from Rider University in Lawrenceville, NJ.
Chris Conway
Worldwide Life Sciences
Chris joined the GBG team in 2009. As the President of both WWLS and Bioplast Manufacturing, he oversees the development of the Sales and Manufacturing Division of GBG. As part of this development, he continuously strives to create and realize efficiencies that can help both entities become more competitive in the global life science and injection molding marketplace.
Chris initially joined Medical Diagnostic Laboratories, L.L.C. (MDL) IT Department as an IT Network Administrator in 2003 and has since held various management positions of increasing responsibility. He moved into MDL's Purchasing Department as the Purchasing Manager in 2004. In 2004 he cofounded WorldWide Life Sciences and held the position of Director of Operations until 2015 when he was appointed President of WWLS. Chris is also a cofounder of Bioplast Manufacturing where he held the position of Director of Operations from 2009 until 2015 when he was appointed President of Bioplast as well.
Chris received his BS in Information Technology from Richard Stockton University of New Jersey (formerly Stockton State College) in Galloway, NJ.
Joseph Capalino
Director of Revenue
Medical Diagnostic Laboratories, L.L.C.
Joe joined the GBG team in 2014. As the Director of Revenue, he is responsible for the overall operations and various teams within the billing department. Joe oversees the billing of Managed Care Organizations, patient's, and client's as well as reimbursement and collection activities.
Joe brought 20 years of experience in the Medical Billing industry to the GBG Team. He was the owner of Apex Resource which focused on Medical Billing.
Joe received his BS in Accounting from St. Joseph's University in Philadelphia, PA.
Kathryn T. Iacono, Ph.D.
Director of Administration
Medical Diagnostic Laboratories, L.L.C.
Dr. Iacono joined the GBG team in 2006. As the Director of Administration, she is responsible for overseeing the Customer Service and Data Entry divisions. She serves as a technical specialist to both physician clients and patients whereby she addresses questions concerning MDL's testing platforms and methodologies as well as treatment options and interpretation of laboratory results for physicians and other healthcare practitioners.
Dr. Iacono began her career with MDL in the Research & Development Department as the Clinical Development Team Leader. In 2014, Dr. Iacono transitioned into the roles of Technical Sales Specialist and Customer Service Manager within the Administration Department. In 2015, she was promoted to her current position as Director of Administration.
Dr. Iacono received her BS in Biology from Muhlenberg College in Allentown, Pa. She earned her Ph.D. in Molecular Biology & Genetics from the Department of Molecular Biology and Genetics/Fels Institute for Molecular Biology and Cancer at Temple University School of Medicine in Philadelphia, PA. Dr. Iacono completed her post-doctoral fellowship in Neurovirology at the University of Pennsylvania in Philadelphia, PA.
Michael McQueney, Ph.D.
Managing Director
Oncoveda Cancer Research Center
Dr. McQueney joined the GBG team in 2009. As the Managing Director of Oncoveda Cancer Research Center, he oversees all research efforts currently focused on the discovering and optimizing novel small molecules to induce the immune system to attack tumors as a way to treat cancer. Dr. McQueney's group is taking a two pronged approach by looking for ways to both induce an innate immune response and to inhibit immunosuppressive molecules already in the tumor microenvironment. Oncoveda identifies new immuno-oncology drug targets and develops novel assays to be used in high throughput screening and in medicinal chemistry efforts to optimize screening hits into new drugs.
Dr. McQueney began his career with VENENUM Biodesign as the Assistant Manager of High Throughput Screening. In 2011 he became the Screening and Compound Management Team Leader, a position he held until 2014 when he became the Discovery Biology Senior Team Leader. In 2016, Dr. McQueney transitioned into his current role as the Managing Director of Oncoveda Cancer Research Center.
Dr. McQueney brought 14 years of experience in Drug Development to the GBG Team. He previously held positions at SmithKlineBeecham as an Investigator and at GlaxoSmithKline as a Manager.
Dr. McQueney received his BS in Chemistry from Millersville University of Pennsylvania in Millersville, PA. He earned his Ph.D. in Bioorganic Chemistry at University of Maryland in College Park, MD. Dr. McQueney completed his post-doctoral fellowship in Cancer Research at Fox Chase Cancer Center in Philadelphia, PA.
Chiayu (Joyce) Huang, Ph.D.
Director of Chemistry
Genesis Biotechnology Group
Dr. Huang joined the GBG team in 2010. As the Director of Chemistry, she oversees a team of medicinal chemists in the optimization of small molecule therapeutic compounds aimed at immuno-oncology targets, metabolic disorders, and infectious disease. She also guides the bioanalytical characterization of lead molecules through pharmacokinetic and Absorption, Distribution, Metabolism and Excretion (ADME) studies. In addition, Dr. Huang is responsible for the maintenance and growth of Venenum's 5.7 million member compound collection for high-throughput screening.
Dr. Huang began her career with VENENUM Biodesign as a Chemistry Team Leader. In 2015 she was promoted to Assistant Director of Medicinal Chemistry a position she held until 2019 when she transitioned into the role of Director of Medicinal Chemistry.
Dr. Huang is a medicinal chemist with more than 20 years of experience in drug discovery which spans a variety of therapeutic areas including Metabolic Disease, Oncology, Respiratory, CNS, and Inflammatory Disease. She previously held positions with Pharmacopeia as a Research Scientist and Senior Group Leader as well as Ligand Pharmaceuticals as a Senior Research Investigator.
Dr. Huang received her BS in Chemistry from National Taiwan University in Taipei City, Taiwan. She earned a Ph.D. in Organic Chemistry at University of Texas at Austin in Austin, TX. Dr. Huang completed her post-doctoral fellowship in Organic Chemistry at Duke University in Durham, NC.
James Beasley, Ph.D.
Director of Biology
Venenum Biodesign
Dr. Beasley joined the GBG team in 2011. As Venenum's Director of Biology, he oversees a team of scientists that support the research efforts in GBG's pre-clinical drug discovery programs in therapeutic areas such as metabolic disorders, oncology, and infectious disease. Dr. Beasley's Discovery Biology team specializes in the development, optimization, and execution of assays in the ultra-high-throughput screening (uHTS) of Venenum's 5.7 million member compound library. The team also develops and performs assays, including several ADME-Tox assays, necessary to profile the small molecule therapeutic compounds produced by medicinal chemistry. Dr. Beasley serves as a member of the GBG Executive Council.
Dr. Beasley began his career with VENENUM Biodesign as the Discovery Biology Team Leader. In 2014 he was promoted to his current position as Director of Discovery Biology.
Dr. Beasley brought 12 years of experience in the Drug Discovery industry. He previously held positions with Ligand Pharmaceuticals as a Senior Research Investigator, Pharmacopeia as a Senior Principal Scientist, and DGI Biotechnology as a Senior Scientist.
Dr. Beasley received his BS in Chemistry from University of Texas at Austin in Austin, TX. He earned his PhD. in Chemistry at University of North Carolina at Chapel Hill in Chapel Hill, NC. Dr. Beasley completed his post-doctoral fellowship at Princeton University in Princeton, NJ.
Joseph Nickels, Ph.D.
Institute of Metabolic Disorders
Dr. Nickels joined the GBG team in 2007. As the Managing Director of the Institute of Metabolic Disorders, he oversees all research efforts currently focused on the discovery and development of novel therapeutics, with a special focus on for the treatment of lipid-dependent fatty liver disease (NAFLD/NASH).
Dr. Nickels began his career with MDL in the Research & Development Department, Division of Pharmacogenomics as a Team Leader. In 2009 he transitioned into the role of Scientific Director of VENENUM Biodesign and then Director of Target Biology in 2010. In 2012, Dr. Nickels became the Managing Director of the Institute of Metabolic Disorders.
Prior to joining GBG, Dr. Nickels was a professor of Molecular Biology at Drexel University College of Medicine in Philadelphia, PA for ten years. He has continued his role in Academia in recent years at UMDNJ-School of Osteopathic Medicine in the Department of Molecular Biology and Rowan University School of Medicine in the Department of Molecular Biology.
Dr. Nickels received his BS in Biochemistry from Rider University in Lawrenceville, NJ. He earned his Ph.D. in Molecular Genetics and Microbiology at Rutgers University in New Brunswick, NJ. Dr. Nickels completed his post-doctoral fellowship in Genetics at Princeton University in Princeton, NJ.
William Hord
Director of Operations
Medical Diagnostic Laboratories, L.L.C.
Bill joined the GBG team in 2009. As the Director of Operations, he oversees the Logistics, FST, Shipping & Receiving, Warehouse, Fleet and Operations divisions and personnel. Bill is responsible for ensuring the efficient and timely transport of all specimens to the laboratory. He continuously works to develop new processes and procedures to increase efficiencies and drive down ever growing operational costs. He works to improve the business processes for the department through analysis and collaboration with other departments.
Bill joined MDL as the Operations Manager of Sherute, LLC., a position he held until 2011 when he became Assistant Director of Operations. In 2016, Bill transitioned into his current role as Director of Operations of MDL.
Bill brought more than twenty years of experience in Operations and Facilities Management to the GBG team. He proudly served his country in the US Navy as an Operations Specialist 2nd Class Petty Officer with a concentration in Combat Information Center Operations. He previously held positions at California Closet Company as a Foreman with a concentration in cabinetry and at Congoleum Corporation in Administrative Services as a Facilities Manager.
Bill received a Certificate of Completion from the US Navy Nuclear Power "A" School and has been working towards a BA in Business Management from Rider University College of Continuing Studies.
Kim Cabets
Director of Quality Assurance
Medical Diagnostic Laboratories, L.L.C.
Kim joined the GBG team in 1998. As the Director of Quality Assurance, Kim is responsible for maintaining federal and state licensing for the Clinical Laboratory as well as all regulatory compliance.
Kim joined MDL as a Laboratory Technician in 1998 and has since held various management positions. She was manager of the Clinical Laboratory until 2007 when she became Director of the Quality Assurance (QA) & Quality Control (QC) Department. She held this position until 2012 when she became Director of Quality Assurance, enabling her to focus on licensing and regulatory compliance issues.
Kim received her BS in Biology from Temple University in Philadelphia, PA.
Peter Golden
Director of Operations
Pete joined the GBG team in 2006. As the Vice President & Director of Operations, oversees the operations of construction and facility services for Sherute LLC.
Pete initially joined MDL as a Project Manager. In 2007 he transitioned to the position of Project Manager for Sherute, LLC. In 2009 he became Senior Project Manager, a position he held until 2014 when he assumed his current role as Vice President & Director of Operations.
Pete brought 14 years of experience in the construction industry to the GBG Team. He previously held positions at CHR Construction Inc., as Project Manager with a focus on residential construction, DRB Developers and Builders LLC., as Carpentry Foreman and Project Manager with a focus in Residential & Commercial Construction, and Advanced Construction Group LLC., as Carpentry Foreman and Project Manager with a focus of commercial construction.
Pete received his AA in General Studies from Clarks Summit University in South Abington Township, PA. He has also completed additional course work in Project Management Studies at Mercer County Community College in West Windsor Township, NJ.
Jon C. Sniffen, MDxt (AAB)
Director of Laboratory Operations
Jon joined the GBG team in 2002. As the Director of Laboratory Operations of SunPath-MDL, he is responsible for overseeing and managing all aspects of clinical laboratory operations including recruitment and employment needs of all laboratory personnel. Jon oversees the training and development of all laboratory technical personnel. He monitors compliance with all applicable regulations and provides day-to-day on-site supervision of specimen processing, test performance, and analysis.
Jon began his career with MDL as a Laboratory Technician in 2002 and has since held various positions of increasing responsibility including Assistant Coordinator, Second Shift Coordinator, Laboratory Technology Manager. In 2017 Jon was promoted to his current position of Director of Laboratory Operations for SunPath-MDL.
Jon received his BA in Molecular Biology from Rutgers University in New Brunswick, NJ.
Meagan Fuscaldo
Director of Sales
WorldWide Life Sciences (WWLS)
Meagan joined the GBG team in 2013. As the Director of Sales of WWLS, she oversees the development of the Sales Division of Worldwide Life Sciences. To continue the growth and success of the distribution leg of the GBG organization, Meg strives to develop a robust and highly effective sales team, partnering expertise in a variety of scientific disciplines while bringing value to customers nationwide through consultative and reliable end user experiences.
Meagan initially joined WWLS as a Laboratory Consultant in the Virginia Territory. She has since held various management positions of increasing responsibility including BMT Channel Manager, District Manager, and Senior Business Development Manager.
Meagan earned her B.S. in Biology from Virginia Commonwealth University in Richmond, Virginia. Following her undergraduate studies, she completed post-baccalaureate studies in Human Anatomy and Physiology at Georgetown University in Washington, D.C.
Boris Bogomolnik
Director of Information Technology
Boris joined the GBG team in 2017. As the Director of IT he is responsible for the strategic planning, design, implementation, and overall alignment of all technology infrastructure with the organizational goals GBG and its member companies. Boris directs the effective delivery of networks, applications, and disaster recovery and processes. He oversees a team of technology engineers, architects, and developers while working closely with management, external vendors, and advisors. Boris identifies solutions to manage daily business activities more efficiently through technological improvements which increase productivity and reduce costs and downtime.
Prior to joining GBG, Boris brought with him twenty years of experience in the information technology industry. He previously held positions as technical lead senior solution advisor at Anthem BC/BS and team lead of application modernization at Gap Gemini America.
Boris received his BS in Information Technology at Kiev National Polytechnic University in Kiev, Ukraine.
Joseph A Peters, MBA, CGMAe
Chief Financial Officer, Genesis Drug Discovery and Development (GD3)
Chief Operating Officer, PharmOptima
Joe joined the GBG team in 2017 as a result of GBG's purchase of PharmOptima. As the Chief Financial Officer for GD3, he is responsible for the accounting and finance functions which include financial reporting and budget projections for all GD3 companies. Joe also manages the onsite staff and day-to-day operations of PharmOptima from an administrative perspective including human resources, information technology and facility maintenance.
Prior to joining GD3, Joe brought with him eight years of experience in the financial side of the Pharmaceutical industry. Joe previously held a position in Financial Reporting / Internal Control Compliance at Perrigo in Allegan, MI.
Joe received his BBA in Accounting from Western Michigan in Kalamazoo, MI. He earned his MBA from the University of Notre Dame in Notre Dame, IN. His current professional membership includes the American Institute of Certified Public Accountants.
Joe's hobbies include reading, tennis, boating and remaining active in his local church.
Caitlin Capestro
Director of Business Development
Bioplast Manufacturing, L.L.C.
Caitlin joined the GBG team in 2012. As the Director of Business Development, she is responsible for maximizing sales coverage enhancing growth and increasing market share as a leading manufacturer in the plastic labware industry. Caitlin promotes continuous development among Bioplast Manufacturing's existing relationships and identifies, coordinates and pursues sales efforts with prospective customers.
Caitlin began her career with GBG as a Laboratory Consultant for WorldWide Medical Products Sales Division in 2012. In 2015 she became the Refrigeration Channel Manager and in 2016 MidAtlantic District Sales Leader. In 2017 Caitlin was promoted to Senior Business Development Executive, a position she held until transitioning into her current role with Bioplast Manufacturing.
Caitlin received her BS in Communication Studies from The College of New Jersey in Ewing, NJ.
In her spare time, Caitlin enjoys traveling, reading, spending time at the beach or on the water, and being with family & friends.
Rukiye Nazan Eraslan, Ph.D.
Managing Director
Dr. Eraslan rejoined the GBG team in 2019. As the Managing Director of Invivotek, she leads a cross-functional team of scientists who conduct pre-clinical studies that enable interrogation of immunotoxicity, mechanisms of action, diagnostic hypotheses and ensure target engagement and pathway analysis activities to support target identification and immunotherapy in autoimmune diseases and oncology. She leads the scientific negotiation and due-diligence as a first layer to deliver decisional statements and explain data driven scientific rationale in to business. Rukiye also provides program/project management and operational support for drug development programs/projects (DDPP) to maintain accurate plans and documentation.
Dr. Eraslan began her career with GBG in 2013 at Invivotek as Team Leader, Immunology/Oncology, a position she held for over 3 years. In February 2019, she returned to the GBG family to become the Managing Director of Invivotek.
Dr. Eraslan brought over 20 years of experience in Immunology and Oncology within multi-disciplinary matrix teams comprised of colleagues from various groups including Discovery, Safety, Clinical and Regulatory to develop and deliver biomarker strategies and potential combination therapies for IO and autoimmune diseases assets. She previously held positions at Xenogen/Caliper Life Sciences as Team Leader Immunology & Inflammation, Taconic, Inc., as Team Leader/Principal Scientist Immunology & Inflammation, and (Bristol Mayer Squibb (BMS) as Principal Scientist as Immuno-Science and Oncology.
Dr. Eraslan received a M.S. in Molecular Biology from Illinois Institute of Technology in Chicago, IL. She earned a Ph.D. in Immunology at University of Illinois in Chicago, IL. Dr. Eraslan completed her post-doctoral fellowship in Immunology at Northwestern University Medical School in Chicago, Il.
Jennifer Goff
Vice President of Sales
Geneveda, Division of Genetics & Oncology
Jennifer joined the GBG team in 2009. As the Vice President of Sales, she is responsible for developing strategic sales plans based on company goals to promote sales growth and customer satisfaction. She also hires, develops and manages the Geneveda Genetic Sales Team while maintaining a culture of team work, success and ongoing business and goal achievement.
Jennifer joined Medical Diagnostic Laboratories, L.L.C. (MDL) in 2009 as an Account Manager. She has since held various positions of increasing responsibility including Senior Account Manager, Senior Sales Executive, and District Sales Manager. In 2014 she was promoted to Sector Sales Manager, a position she held until becoming the Vice President of Sales in 2017.
Jennifer received her BA in Advertising from Western Kentucky University in Bowling Green, KY.


text:
Product Description
Ted Baker Rugs
Hand tufted, woven and printed rugs combining Ted Baker's eye for style and Brink and Campman's craftsmanship.
Iconic prints and head turning colours including a range of round rugs.
Custom sizes available.
Free delivery in 5-7 days. Free Exchange on this range - Click HERE
Get 10% off your first order using promotion code HINT0210

subset: commoncrawl


text: Lesbian leglock sex. Can Vicky beat her down and what kind of sexual technique will she use to bring her to a strong orgasm?? Young Asian Porn. All material on this site, including, but not limited to images, illustrations, sex girls games clips, and video clips collectively the "Material" is protected by copyrights owned or controlled by Hierodule Productions Ltd. These two strong and sexy newcomer challenge each other to a fingerlock contest at the beginning and the winner is decided by most submissions. Busty Japanese mature woman part6. A rivalry between a Boss Lady and the new Girl in town. If you like experience women in erotic battles, you will love it. Bonus Mona69 vs Vanessa Cool grind, rub and stick there love lips together with leg locked rolling in a hot 4 round sexfight duell. Mature Adila fucks with guy at the pool.


text:
Book your holiday party in HarborPoint before November 15,
and receive a 10% discount.
Thank you for considering HarborPoint at Root for your next event. We look forward to working with you to create a wonderful experience for you and your guests. With spectacular water views of historic Salem Harbor and a state-of-the-art open kitchen, HarborPoint at Root is a flexible, urban-chic space that can be tailored to accommodate your vision and the needs of every gathering.
Whether a corporate meeting, wedding, rehearsal dinner, fundraiser or other social event, our skilled team is here to assist you to create a memorable occasion.
HarborPoint at Root
2,200 square feet of urban chic space
Dimensions of HarborPoint Room: 45'10" by 46'8" with 15' ceilings
Accommodates 150 people seated theater-style, 110 at tables, or 300 for a reception
Large windows overlook Salem Harbor and historic Derby Wharf Lighthouse
Three (3) ADA compliant restrooms
Abundant free parking
Root accepts MasterCard, Visa, Discover, and payment by check.
For questions or to book an event, please call:
Chris Haley
Events Manager
(978) 616-7615, ext. 105


text:
Hand-built exclusively to order in our Cambridge UK factory, every Edelweiss Piano is an original in its own right. Tailored precisely to your unique requirements both in terms of touch & sound as well as design & style, our Master Artisans delight in producing bespoke musical masterpieces specifically for you. Faced with a limitless array of colour, design and style choices though, how do you define exactly what you want your custom piano to be? This particular client was inspired by a piano he saw featured in a YouTube video.
Inspired by a Design First Seen on YouTube
Inspiration comes from the most surprising places – from the beautiful Le Silex musical sculpture that took inspiration from a rock shattered by a lightning strike, to the famous 'Leaking Piano' that was conceptualised whilst contemplating the wax dripping from a candle flame, to this beautiful instrument that features a design our client remembers from a Lola Astanova YouTube video!
With a clear vision of what the final design needed to incorporate – the bespoke hand-painted checkerboard lid and music desk – our Piano Design Team set to work with the client finalising ideal size and preferred colours for his custom piano. For final delivery into his Hong Kong penthouse, the Edelweiss G50 Sygnet was selected due to it's petite footprint and distinctive butterfly lid which would really help emphasise the checkerboard finish our client was looking for.
Small is Beautiful
Having confirmed the suitability of this custom made piano model for our clients home using a combination of CAD models and actual floor templates, we were ready to consider design & style options and our client's preferred colour palette. Considering our clients tastes in furniture styles and other feature pieces in his home, the 'Deco' leg style was chosen to give the piano a unique piano style as well as a special finish, and it didn't stop there. The video our client had seen featured a black grand piano with a black & white checkerboard lid … but our client had always dreamed of a beautiful white grand piano and felt that a white piano with contrasting black checkerboard lid would be too 'aggressive' for his home. Our design team went back to the moodboards we had created and a gentle shade of 'Pearl Beige' was chosen married with a Pearlescent White to give the whole piano a shimmering, immersive allure. Needless to say, but our client is delighted with his bespoke musical masterpiece – what design inspiration would you follow to create your custom piano? We'd love to hear your ideas on firstname.lastname@example.com or call +44 (0)1223 881691.


text:
High bed Douglas fir, Made in Germany
High bed
|Species of wood: Douglas fir
Version: untreated, with plant film, with centre strut*
|Dimension: 70 x 150 cm
Height: 72.5 cm
|Dimension: 100 x 200 cm*
Height: 72.5 cm
Douglas fir is both durable and resistant and also offers high strength. This species of wood also has natural resistance to insect attack, with its high resin content acting as a sort of natural timber preservative. With Douglas fir you are buying local timber – Made in Germany.
- Solid, high-quality workmanship
- Resistant and durable
- Environmentally friendly
- Natural resistance to insect attack
- Fast and easy to install


text:
Makeup-mirrors-with-lights, this vanity mirror with lights up to 3x magnification and super reviews is on i have a mirror just like this one and use. Undoubtedly ladies love their time in front of the mirror the flawless look is achieved after careful effort the most important condition for the right makeup application is sufficient light the, easehold a world leader of smart homeware released a brand new versatile and portable led makeup mirror this 7 inch rechargeable smart mirror is extremely practical and functional providing. The mirror is an impressive piece of technology it senses your movement and automatically lights up as your face gets near you know that annoying thing where your makeup is bomb in your mirror, i can do my makeup just fine using the two large mirrors currently so you can place your phone in the included clip mount it and turn the entire mirror into a giant light up selfie station.
The fascinating people who inhabit the amazon comments section have a number of thoughts when it comes to which makeup mirror with lights you should be using whether you need stage lights or a small, wireless intelligent make up mirror is a latest technology mirror it is as a mirror when you cosmetic and it can be as a charging bank for your phone which there is.
But beyond their glamorous connotations what can light up mirrors actually do to help improve application our compacts may well be handy for on the go but to get the best out of our makeup first, whether you need a makeup mirror with smarts or one that you can travel with we have a pick for you in our guide to the best makeup mirrors. Instead of waiting for the perfect ray of sunshine let the spotlite makeup mirror do the work for you time to say goodbye to your fluorescent lights lighting is one of the most important tricks in, known fact: natural lighting is best when it comes to applying your makeup but just because a good dose of sunshine helps you apply your foundation flawlessly doesn't mean it's easy to come by what.
Search skip to navigation skip to main content skip to related content mail


text:
The countdown begins now!!!
Here are the next five writers that you voted as your favorites of all-time (out of roughly 1,008 ballots cast, with 10 points for first place votes, 9 points for second place votes, etc.).
45. Matt Fraction – 223 points (2 first place votes)
In his early series, Casanova, Matt Fraction had a good deal of fun with the comic book format and trying new approaches of comic storytelling. That inventiveness has carried over to his current work, Sex Criminals, which Fraction has been working on with artist Chip Zdarsky for years now. In Sex Criminals, Fraction uses a blend of humor and compelling characters to tell engaging pairings, like when Suzie meets Jon at a party in Sex Criminals #1. Suzie has the ability to freeze time when she orgasms, so she is shocked when she learns that she is not alone...
This type of offbeat interaction is what drove Fraction's stellar Hawkeye series, as well, where Fraction developed the female Hawkeye, Kate Bishop, into one of the top female characters in the entire Marvel Universe, while also revitalizing Clint Barton's comic career. In fact, Fraction and artist David Aja's innovative approach to the Hawkeye series (mostly taking the series away from standard superhero stories and focusing on the human aspects of Clint Barton) make it probably one of the most influential Marvel Comics of the past ten years. Lots of acclaimed Marvel series can trace their beginning back to Hawkeye, in one shape or form. In fact, if you took a random Marvel Comic book from, say, 2005 and a random Marvel Comic book from this week and compared them to one of Fraction's Hawkeye issues, I would bet you donuts to dollars (at least here in NYC, donuts are more than a buck nowadays) that they are most comparable to Hawkeye. That is how big the influence of Fraction's work was.
Between Casanova and Sex Crminals, of course, Fraction also made a major name for himself writing nearly all of Marvel's major characters, including a long run on Iron Man and significant stints on Uncanny X-Men and Thor. He also wrote one of the greatest tributes to the Peter Parker/Mary Jane Watson marriage ever in a Sensational Spider-Man Annual one year. That comic got a lot of support in our recent "Top One-Shots of All-Time" poll, but fell just a bit short of the Top 50 (the #51 story period was the first appearance of Death, by the way, just in case anyone was curious).
44. Keith Giffen – 230 points (1 first place vote)
Keith Giffen has worked as a plotter on a number of classic series, from his beginning on Legion of Super-Heroes with Paul Levitz to his continued work on the Legion (where he and Tom and Mary Bierbaum dramatically altered the world of the Legion). He has done flat-out humor with Ambush Bug and he has done more serious fare (like his Magnus: Robot Fighter series that he scripted as well as plotted). Here's a bit from his first Ambush Bug series, making fun of the changes in DC's continuity following Crisis on Infinite Earths...
His most famous work, though, is definitely his run on Justice League with scripter J.M. DeMatteis. The concept of the book is that Giffen had to come up with an idea for a Justice League series after most of the top heroes were now no longer available to him after Crisis.
Without the major heroes, Giffen instead attempted to develop the personalities of the heroes they WERE given, particularly once two of the heroes they were given, Blue Beetle and Booster Gold, lost their individual series, as that gave Giffen free reign with how to write them. Giffen also spotlighted the League liaison, Maxwell Lord, who formed the team for fairly nefarious reasons but soon turned out to be a good guy. Later on, due to a lack of female characters on the team (and lack of notable female heroes available period) when Canary was taken from them, Giffen added two obscure members of the Global Guardians who soon became stalwart members of the team, Fire and Ice.
The book is most known for the humor of the title, which was a major aspect of the book - it really was a situation comedy.
Here is the first usage of "Bwah Ha Ha" that shows what the comedy of the book was like...
Giffen and DeMatteis built this strange superhero book up to becoming one of DC's most popular comics for five years! They are currently writing Scooby Doo Apocalypse, which deftly matches their use of humor and darkness.
43. John Ostrander – 242 points (4 first place votes)
John Ostrander got into comic book writing relatively late, as his first career was in the theater. He has more than made up for lost time over the last thirty years, first at First Comics, writing Grimjack and then at DC Comics, writing the Suicide Squad and Firestorm and later The Spectre (plus various other mini-series and a run on Martian Manhunter).
Ostrander excels at coming up with multi-faceted characters and then playing them off against each other in thoughtful plots. His work on The Spectre had some of the most interesting comic book discussions of religion out there. In the Suicide Squad, he developed one of the great new characters of the 1980s in Amanda Waller, the conflicted head of the Suicide Squad. Check her out standing toe to toe against Batman (who had infiltrated the prison that the Suicide Squad used as a home base to investigate rumors of the government using supervillains as operatives)....
Another major character who was introduced in Suicide Squad was Oracle. You see, after the Killing Joke, Ostrander and his wife, Kim Yale, were irritated at how Barbara Gordon was used in that story. Yale, in particular, really wanted them to try to find a way to give Barbara Gordon some agency back, so the two of them came up with the idea of making Barbara a computer hacking superhero, all while in a wheelchair, thus giving the world the most notable hero in a wheelchair since Professor X!
Ostrander also wrote for Dark Horse's Star Wars line for years, including launching one of the best Dark Horse Star Wars series of all-time, Star Wars Legacy (set 125 years after Return of the Jedi). He is currently working on two new series with his longtime collaborators, Jan Duursema and Tom Mandrake (Duursema did most of Ostrander's Star Wars work and Mandrake did Firestorm, Spectre and Martian Manhunter). The Mandrake one is a vampire story called Kros: Hallowed Ground and the Duursema one is a sci-fi tale called Hexer Dusk.


text:
- Prostitutes An Nāşirīyah
- Serbia
- Prostitutes Valjevo
26 Best Valjevo images | Belgrade, Serbian, Serbian language Prostitutes Valjevo
- Telephones of Escort Valjevo
- Red Dead Redemption 2 - Arresting Prostitute & Watching Her Hang (video)
- Telephones of Whores Valjevo Central Serbia 3188402
There were cases of women Prostitutes shorn in Italy because of collaboration with the German occupiers after Prostitutes capitulation. Trade Valjevo in Serbia were turned into workshops where women and girls sewed clothes for soldiers, volunteers, the Red Crossand National Defense. During the war and occupation ofSerbian women were victims of diverse and atrocious forms of persecution - Valjevo violence, beatings, and forced displacement.
The original verdict was contested when the statement made by the main witness was challenged since his motivation was revenge of a rejected man. Sergeant Major Flora Sandes of the Serbian army, Many have come through there, some of them were young, some of them were older, and they were usually from poor families - said the neighbors. Nor was the impact of such behaviour on public opinion that closely monitored the behaviour of women negligible.
Telephones of Escort Valjevo
Punishment by cutting hair as well as post-war trails, beside real charges for sexual relationships had, in numerous cases, background in ideological disapproval. The Military-General Government determined that in there were 40, fewer women than in Reale ficktreffen Jena
Red Dead Redemption 2 - Arresting Prostitute & Watching Her Hang
Telephones of Whores Valjevo Central Serbia 3188402
There are witness reports that the SS and Police Commander of Belgrade August Meisner had two mistresses who were sisters Prostitutes came from a respectable Belgrade family — Prsotitutes were shot after the war.
WL champions Serbia start defending title The Serbia men's national water polo team has got off to a successful start to its title defense at the World League in Huizhou, China.
Istorijski Valjevo.
|Central Serbia
|Table of Contents
Penguin books.
- Patriarchal moral rules regulated the behaviour, love life and sexual life of women with special strictness.
- Version 1.
- The girl Proxtitutes not accept the suggestion of Field Marshal Radomir Putnika Chief of Staff, to participate in the war effort as a nurse.
- On early evenings, they went Prostituted do housework and settle cattle.
- In some way, each activity was focused on the war effort - in addition the task of basic survival.
- There were cases of women being shorn in Italy because Prostitutea collaboration with the German occupiers after the capitulation.


text:
Janice F. Mulligan
Attorney Profile
Top Rated Personal Injury Attorney in San Diego, CA
San Diego, CA 92101
- Personal Injury - General: Plaintiff (50%),
- Personal Injury - Medical Malpractice: Plaintiff (30%),
- Insurance Coverage (10%),
- Class Action/Mass Torts: Plaintiff (10%)
Clients describe Janice Mulligan as both compassionate and aggressive. Throughout her career, she has successfully battled large corporations and insurance companies seeking to deny just compensation for losses. For over 30 years, Ms. Mulligan has been representing individuals and families who have experienced life-changing serious injuries and/or wrongful death from traumatic events including medical malpractice, product liability, car accidents and/ or nursing home abuse. On the cutting edge of innovative legal issues, Ms. Mulligan also has advanced knowledge and experience in helping people in potential class action lawsuits arising from cyberattacks on personal health data, stem cell and/or other medical fraud.
She is acknowledged for her professional skills by her peers, receiving the Top Gun Award for a medical malpractice verdict by the Orange County Bar Association (2018) and finalist for Trial Lawyer of the Year by the Consumer Attorneys of San Diego (2018). The American Bar Association TIPS also awarded her with the James K. Carroll Leadership Award in 2015. Other honors include an award for Service to the Legal Profession by the San Diego County Bar Association and the Belva Lockwood Award by the Lawyers Club. Her written skills are also exemplary: Ms. Mulligan has been recognized by the Press Club of San Diego, and awarded best scientific paper by the UIA in Valencia, Spain in 2015.
She is a proven leader in the community, serving on several prominent boards and committees. Ms. Mulligan is the president of the Health Law Commission of the International Association of Lawyers (UIA), and the chair of the American Bar Association (ABA) TIPS Cybersecurity & Data Privacy Committee, She is a past-chair emeritus of the ABA Standing Committee on Medical Professional Liability and a former member of the ABA Standing Committee on the American Judicial System. Ms. Mulligan also recently completed a term as a Commissioner on the State Bar of California's Judicial Nominee Evaluation Commission (JNE).
She frequently teaches lawyers courses in medical malpractice, cybersecurity and big health data, trends in personal injury law and trial techniques. Ms. Mulligan previously served as a clinical instructor at the University of California San Diego Medical School, where she taught physicians and medical students laws related to patient safety issues and medical ethics.
In addition to her team of experienced trial attorneys, a board-certified physician is also on staff at Mulligan, Banham & Findley to assist with case selection and preparation. Throughout her tenure as a personal injury attorney, Ms. Mulligan has also amassed a network of some of the most qualified medical experts in the country to ensure premier assistance. In doing so, she has secured hundreds of millions of dollars for clients in specialized areas of personal injury.
Personal Injury - General: Plaintiff (50%)
Personal Injury - Medical Malpractice: Plaintiff (30%)
Insurance Coverage (10%)
Class Action/Mass Torts: Plaintiff (10%)
Personal Injury - General (50%): Motor Vehicle Accidents, Personal Injury - Plaintiff, Slip and Fall, Wrongful Death, Brain Injury, Trucking Accidents, Premises Liability - Plaintiff
Personal Injury - Medical Malpractice (30%): Medical Malpractice, Birth Injury
Insurance Coverage (10%): Bad Faith Insurance
Class Action/Mass Torts (10%)
Motor Vehicle Accidents, Personal Injury - Plaintiff, Slip and Fall, Wrongful Death, Brain Injury, Trucking Accidents, Premises Liability - Plaintiff, Medical Malpractice, Birth Injury, Bad Faith Insurance
Super Lawyers: 2007 - 2019
To: Janice F. Mulligan
Super Lawyers: Potential Client Inquiry
Additional Sources of Information About Janice F. Mulligan
About Janice Mulligan
Admitted: 1981, California
Professional Webpage: http://www.janmulligan.com/lawyers/janice-f-mulligan/
- Award for Contributions to the Legal Profession, San Diego County Bar Association, 2006
- Following a medical malpractice case where the defendant hospital made no offer, Ms. Mulligan and her law partner Brian Findley, obtained a $5.5 million dollar jury verdict. The day following the unanimous verdict, the jury visited the grave of the deceased patient, leaving a note of sympathy and respect for his spouse. Two separate awards were given for this jury verdict, naming Ms. Mulligan "Top Gun in Medical Malpractice" by the Orange County Bar Association and "Trial Star" by the Consumer Attorneys of San Diego, 2018
- Belva Lockwood Award for Contributions to the Legal Profession, Lawyer's Club, 2001
- AV-Pre-Eminent Rating by Martindale-Hubbell
- In 2015, Ms. Mulligan was given an award for the best scientific paper at an international congress held by UIA in Valencia, Spain for her treatise entitled: How Would You Like Your Pacemaker to be Hacked? Health Care Cyber Vulnerability A copy of the paper is available at: http://www.janmulligan.com/wp-content/uploads/2015/05/UIA-Mulligan-cybersecurity-paper-for-publication-oct-20151.pdf, International Association of Lawyers (UIA)
- Outstanding Advocacy Award, Consumer Attorneys of San Diego, 2008
- Leadership Award , American Bar Association, TIPS , 2013
Special Licenses/Certifications:
- Center for International Legal Studies (CILS), Salzburg Austria, Training/ Certification (2010); Gerry Spence Trial Lawyers College (TLC) Certification (2012) with continuing annual graduate courses; Pepperdine University School of Law, Straus Institute for Dispute Resolution, Mediation Certification (2018)
Bar/Professional Activity:
- San Diego County Bar Association, Chair, Lawyer Referral and Information Service, 1985 - 1988
- University of San Diego Alumni Association, Member, Board of Directors, University at Large, 1983 - 1988
- Arbitrator, San Diego County Superior Court, 1988-2009
- Lawyers Club of San Diego, Member, Advisory Board,1998 - 2010
- American Bar Association: Standing Committee on Medical Professional Liability,Emeritus Chair & Liaison to TIPS Council, 2008- 2013; Chair, 2003-2007, Member 1992-2013
- University of California, San Diego, Health Services ,Family Practice & Preventive Medicine Clinical Instructor 2012-2016
- American Bar Association, TIPS Medicine & Law Committee, Chair, 2000 - 2001 member 2000-to date
- San Diego County Bar Association, Member, Board of Directors, 1987 - 1990, Vice-President 1990-1991, member 1981-to date
- Consumer Attorneys of San Diego, Member, Board of Directors, 1986 - 1991, Member 1983-to date
- California State Bar Association, Commission on Judicial Nominees Evaluation (JNE) 2014-2017
- Lawyers Club of San Diego, Chair, Judicial Endorsements Committee, 1999 - 2004
- American Bar Association, House of Delegates, 1998 - 2013
- Union Internationale des Avocats (UIA) Biotechnology Working Group, ViceChair 2013-to date
- American Bar Association, TIPS Chair, Task Force on Plaintiffs' Involvement,2000 - 2002, Member 2000-to date
- San Diego Inn of Court, President 2007-2008 Board of Directors 2000- 2007
- San Diego County Bar Association, Co-Chair, Legislation Committee, 1986 - 1987
- University of San Diego Alumni Association, Member, Board of Directors of Law School, 1985 - 1988
- American Bar Association, Standing Committee on Governmental Affairs, Member 2008 - 2010
- Lawyers Club of San Diego, Member, Board of Directors, 1986 - 1989
- American Bar Association, Council and Member, Tort Trial & Insurance Practice Section (TIPS) 2002 - 2013
- Current Activities: American Bar Association (ABA) Chair, TIPS Cybersecurity & Data Privacy Committee; Delegate, House of Delegates; Member Standing Committee on American Judicial System. International Association of Attorneys (UIA) President, Health Law Commission , 2018
- Welsh Inn of Court, Master, 2007 - Present
Scholarly Lectures/Writings:
- The Textbook of Spinal Surgery, 3rd Ed. Mulligan,JF. Hansen, HH, Uitto,J., Craig,PA, Garfin, SR, "Legal Implications and Strategies",Chapter, Bridwell KH, Editor-in-Chief: The Textbook of Spinal Surgery, Vols. 1 and 2. , co-author, Lippincott Williams & Wilkins, 2013
- Center For International Legal Studies (CILS), Guest Professor, Rezekne, Latvia (October, 2010),Debrecen, Hungary (October, 2011), Lublin, Poland (May, 2013), Salzburg, Austria (May,2015)
- Discovery in the Wandering or Elopement Case Long-Term Care Litigation, Volume 4, Number I (2000), Braun,Julie A., J.D., LL.M., and Mulligan, Janice F., J.D. Reprinted with permission, The Elder Law Portfolio Series, Vol.I, ed by Harry S. Margolies (2006, 2007)
- Litigating the Nursing Home Wandering or Elopement Case Part I: Standard of Care and Discovery (2001) Long Term Litigation 4-5, Braun, Julie A., J.D., LL.M., Mulligan, Janice F., J.D., Reprinted with permission, The Elder Law Portfolio Series, Vol.I, ed by Harry S. Margolies (2006, 2007)
- Litigating Nursing Home Wandering Cases, 2 Elder's Advisor 9-20 (2000),Mulligan, Janice F., Levin, Steven M. Levin, Reprinted with permission, The Elder Law Portfolio Series, Vol.I, ed by Harry S. Margolies (2006, 2007)
- American Bar Association Journal Vol 86 , p. 61, January, 2000, author, Medical Sleuthing, 2000
- American Bar Association, Tort, Trial and Insurance Practice Section, Trial Techniques Taking the Experts' Deposition,(Summer, 2003)
- American Bar Association, Presidential Showcase, Annual Meeting, 10 Rules For Succeeding in a Solo/Small Firm with a Plaintiff's Personal Injury Practice August, 2003, Republished in TIPS Brief, Fall, 2004 edition
- Medical Malpractice in California Handbook, NATIONAL BUSINESS INSTITUTE, (1996 updated 1997, 1998, 1999, 2000 and 2001) DiCaro, J.R., Mulligan, J.F., Reeve, T.B.,
- Elder Abuse Tort Claims in California, NATIONAL BUSINESS INSTITUTE (1999, updated 2000) Fischer, D., Giovanello, A., Mulligan, J.F.,
- HMO's, IPO's, IPP's, When Are Health Care Professionals Liable? ULRICH, NASH, & GUMP, INC. (1999) Diachenko, T.M., Mulligan, J.F.,
- Union Internationale des Avocats (UIA) 56th Congress, Dresden, Germany, Availability of Healthcare in the United States November, 2012
- Union Internationale Des Avocats (UIA) Doctors Without Borders: The Future of Telemedicine Budapest, Hungary May, 2014, Speaker, Co-Chair Biotechnology Law Commission
- How Would You Like it if Your Pacemaker was Hacked? Healthcare Cyber Vulnerability: A Risk Management Nightmare for the 21st Century ,Valencia, Spain , Speaker, Co-Chair Biotechnology Commission, Union Internationale Des Avocats (UIA)
- Brain Software, Genomics and Personalized Medicine: Legal and Biotechnology Challenges, Minneapolis, Minnesota, Speaker, Co-Chair Biotechnology Commission , Union Internationale Des Avocats (UIA)
- Union Internationale Des Avocats (UIA), How Would You Like Your Pacemaker Hacked? Cybersecurity in Healthcare: the Risk Management Headache For the 21st Century October,2015, Speaker, Co-Chair Biotechnology Law Commission
- Numerous multi-million dollar settlements and verdicts
- Silver v. McNamee, 69 Cal. App.4th 269, 1999
Educational Background:
- University of San Diego, J.D., Order of the Coif, 1981
- St. Anthony's College, Oxford University, Oxford, England, 1976-1977
- University of San Diego, B.A. in International Relations, French, May, 1978
Industry Groups
- Lawyers Club
- State Bar Of California
Janice F. Mulligan:
Last Updated: 7/22/2019


text: Under the patronage of MP Ziad Hawat and in cooperation with the Municipality of Jbeil and Bank of Beirut, the old harbor of Byblos saw on Friday the opening of the 5th edition of the Byblos en Blanc et Rose (BBR) wine festival. On the occasion, the general director of the ministry of agriculture, Louis Lahoud, boasted the high standards and quality of the Lebanese wine which promoted it to the level of ambassador to world capitals of Europe and the US, and China, soon. This, Lahoud maintained, is a result of the perseverance of local wine producers, who despite difficulties, managed to force their presence locally and internationally. Hawat, for his part, declared from Jbeil the launch of the wine tourism initiative, with this year's slogan being, 'supporting wine tourism in Lebanon'. This initiative, Hawat stressed, shall offer visitors the chance to explore all the Lebanese provinces, hence bolstering the wine sector. This year, Hawat said, the Lebanese wine will land in Denmark between November 4 and 7, given the importance of the Scandinavian markets, in addition to upcoming exhibitions in August over all Lebanese territories. (Al Diyar, July 7, 2019)


text:
August 21, 2019
No introduction yet
To put it in a nutshell, GDG stands for Google Developer Group and GDG Goa is a community where tech-enthusiasts meet to discuss and work with several Open-Source developer resources and products. A GDG can take many forms — from just a few people getting together to large gatherings with demos and lectures, to events like code sprints and hackathons.
Or sign up with email
Already a member? Log in.
Meetup members, Log in
By clicking "Sign up" or "Sign up using Facebook", you confirm that you accept our Terms of Service & Privacy Policy


text:
Posted: 7:10 pm Thu, March 4, 2010
By Liz Farmer
Daily Record Business Writer
When the parent of Maryland's thoroughbred racetracks filed for bankruptcy and announced it would sell its Maryland properties, it sent a wave of uncertainty, fear and frustration though the state's horse racing community.
Exactly one year later, some say it's gotten messier.
Since it filed for bankruptcy on March 5, 2009, Ontario-based Magna Entertainment Corp. placed Laurel Park, Pimlico Race Course and Bowie Training Center on the auction block, took them off last spring, then put them up back up for auction again last fall.
The company has delayed its Maryland assets auction three times in the last two months, with the latest reschedule — March 25 — adding to the feeling of instability.
It's been a hand-wringing wait for those on the sidelines.
"The most problematic thing here is the uncertainty," said Cricket Goodall, executive director of the Maryland Horse Breeders Association. "You're thinking it's going to happen, and it doesn't. Basically the fate of an industry is in the hands of these people … Every time they set the date, we hope."
And it hasn't been a very coordinated show to watch, said Tim Rice, a racing industry analyst with Rice Voelker LLC in Louisiana.
"There's no question it would have been absolutely impossible for anyone to screw this up more than they've screwed it up," he said.
Most surprising blunder
Rice said Magna's failure to file a licensing fee with its slots application more than a year ago has been its most surprising blunder. Before Magna filed for bankruptcy, subsidiary Laurel Racing Association said it would apply for a license to operate slots at Laurel Park, but the state tossed out the application because it did not include the $28.5 million licensing fee.
The company, which has lost more than $800 million since it bought Maryland's tracks, said then it didn't include the fee because it was not clear if the state would give the money back if Magna was not awarded the license.
"That was probably the one that really sent me for a loop," Rice said. "I just couldn't believe they would pass up that opportunity."
The license for Anne Arundel County was instead awarded to Baltimore-based developer David Cordish, who plans to build a slots casino near Arundel Mills.
Then after flip-flopping on whether to auction its Maryland properties, Magna said last fall it would select a stalking horse bid, an initial bid chosen by the company that competing groups can bid against. But in the winter, the company said it could not reach an agreement and would continue the auction process without a stalking horse. Then in January, the company asked for an auction delay because it said it was trying to work out a deal with an initial bidder after all.
"When the bankruptcy started a year ago, I was cautiously optimistic that in a relatively short time Magna would come out of the bankruptcy, modify the business operations and be in a position to move forward and improve racing, grow racing and develop a plan that's going to transcend for years to come," said Tom Chuckas, president of the Maryland Jockey Club, the Magna subsidiary that operates the Maryland properties and is the entity technically on the auction block. "Unfortunately, sitting here today, there's been a lot of nuances that have delayed or modified that."
The auction sideshow
And now there's the auction sideshow — a campaign by supporters of slots at Laurel to fight Cordish's planned casino development just up the road. The Jockey Club has launched a petition drive to put approval of Cordish's casino on the ballot this fall. Approximately 30,000 signatures have been filed, and roughly half have been approved.
More than 18,000 valid signatures are required to force a referendum, and Cordish has filed a lawsuit challenging the petition drive.
And through it all, the fate of Laurel and Pimlico remains a question mark, with Magna requesting more auction delays — this time without giving a reason. But points of view differ on how closely related the sideshow is to the main one.
Joseph De Francis, who sold the tracks to Magna in 2002 and is now bidding to regain them, called the dispute over slots in Anne Arundel County a "totally separate yet parallel track" to the auction process. He said because Cordish is a bidder for the tracks too, he has a hand in both pots.
"I think Cordish is pulling out all the stops," De Francis said. "I sincerely believe that if that license ends up at the mall, Laurel has no future as a racetrack."
Chuckas said he had not been told why Magna has been delaying the auction.
Jonathan Cordish, vice president of The Cordish Cos., said the auction and the petition dispute are directly connected. He said in an e-mail that Magna's delays "make it clear" the auction is being run solely for the benefit of its parent, MI Developments.
Contrary to state interests
This is contrary to the state and industry's interests, he said, and the result has been further damage to the value of the assets.
"The Jockey Club has deliberately misled the public and the horse racing industry to ensure that MID will not lose the very assets they ruined," Cordish said. "It was clear as each auction approached that we would be the high bidder and not MID or one of its cronies, so they have been delayed again and again. As a result, the Preakness will continue to be an embarrassment to the horse racing industry and our state."
Frank Stronach, the founder of MID and chairman of Magna, and other executives were not available to comment for this story.
The fight in Anne Arundel County is further delaying the opening of what is expected to be the state's largest slots site, which was stalled last year by slow zoning approval. Other slots sites across the state have also met snags, and the first full opening is expected this fall in Cecil County, while a slots parlor in a temporary facility may open at Ocean Downs Racetrack near Ocean City this summer.
The whole picture is a far cry from the $86 million in state revenue that was originally projected for 2009, when legislators passed the slots referendum package in November 2007 that was approved by voters a year later. Goodall said the wait has been hard on breeders, and the length of time Maryland's tracks have sat on the auction block has made it worse.
'You feel so vulnerable'
"You feel so vulnerable I guess because you don't really have a role," said Goodall, of the breeders' association. "You're just watching it play out."
She added that the uncertainty around the tracks and around the future of gaming in Maryland has caused some breeders to either cut down on the number of horses they breed here or to breed out of state. At last count, she said, Maryland's incentive fund to breed and race in Maryland was $4 million — Pennsylvania's is about $25 million. (A small percentage of Maryland's slots revenue is slated to help boost Maryland's incentive fund.)
"Horses have been siphoned off the farms here and are going to Pennsylvania," Goodall said. "People who used to breed 50 mares, it's now a dozen."
Meanwhile, the state's main concern throughout the auction process has been — and still is — keeping the coveted Preakness Stakes — the second leg of the Triple Crown and Maryland racing's biggest moneymaker. The state has several attorneys on the case filing motions, responses and appearing at hearings for anything that may concern Maryland's right to the race.
"We wish this matter had been resolved by now; but our goal is the same," Gov. Martin O'Malley said through a spokeswoman. "To make sure that the winner of the auction makes a binding commitment to the state of Maryland not to move the Preakness."
The first time Magna put Maryland's properties on the auction block, a panic ensued with legislators passing a last-minute bill that allowed the state to seize Magna's Maryland properties — including "intangible property related to the Preakness Stakes" — via eminent domain. The second time around, Magna included a provision requiring prospective bidders to keep the race in Maryland.
O'Malley said based on his conversations with the debtors, he believes Maryland's tracks will have a new owner by the time the Preakness is run on May 15 this year.
Chuckas still optimistic
Chuckas said he was still optimistic that the tracks' future would be resolved soon. While it's been harder on the Jockey Club to operate this past year in an uncertain environment, he said he was "surprised" at how morale has stayed up.
Click here to read rest of story on TDR.


text:
Stock Illustration
Pop Art Man Face With Virtual Reality Glasses
Best Price Guarantee
Found this item somewhere else at a lower price? We'll match it. More details here.
By jemastock
Description: Pop art man excited face with virtual reality glasses technology
Additional Information
- Item ID:
- 107791373
- License:
- Individual License
- Usage:
- Commercial
- Model Released:
- No
- Property Released:
- No


text:
Want to see how I can assist you in your search? Give me a call.
I would love to chat.
I'm never too busy to schedule time with you.
Contact Joseph P. Stengel, Jr.
I am always happy to learn about what you are searching for in understanding a real estate problem or opportunity.
Real estate can be complicated. There are many ways for people to make mistakes when experiencing issues, or when evaluating a real estate opportunity. Those mistakes can come back to hurt you, in a legal sense and a financial one.
Please fill out the form to the right the best you can, or call me so we can chat about your needs.
Joseph P. Stengel, Jr.
Real Estate Attorney Denver
5460 S. Quebec St., Ste. 330
Greenwood Village, CO 80111
- Phone | 720-436-9405
"Joe, I wanted to thank you for the good work you did on my behalf. When I was looking for a real estate attorney in Denver, I picked you after I learned you weren't just a lawyer, but a businessman who has both leased and owned residential and commercial real estate. Your hard work got the job done, and I'm glad I called you."
Lenora F.
Email :
Call me:
Mon-Fri 8:30 am-5 pm (MST)
Find me:
5460 S. Quebec St., Ste. 330
Greenwood Village, CO 80111
www.corealestateattorneys.com -The Colorado Real Estate Blog -Real Estate
Help Tailored To Your Needs
Blog subscribers get my newest real estate insights, information, solutions, and more!


text:
Entry for January 29, 2007
This past weekend I started taking chromium supplements. I started with one on Friday and two on Saturday. The instructions on the bottle says 1-5 per day. The dosage is 200 mcg but after I took the second one, my eyes went itchy and red like it was too much. It's already part of my multivitamin but that only has 20 mcg and I take that twice a day.
So on Sunday, I only take one and it's much better. We all had swiss chalet for dinner and I've had the quarter chicken a couple times since starting the candida diet and it's been fine. Usually I get mushrooms or baked potato but this time, those are definitely out so I get corn instead. Earlier in the week I had swiss chalet with the corn and it was quite good and I didn't notice any obvious side effects.
I fell asleep early last night and woke up around midnight. My nose was really running and I was sneezing like crazy. I was up for three hours and I couldn't get to sleep. This is definitely my allergies and not some cold. I finally got to sleep around 3:30 am. The only thing that I can think of is the corn. I've had it before but I wonder if it was microwaved this time?
I went to work as normal but my nose was constantly running all day long and I was still sneezing like crazy. My eyes are really tired, red and more sensitive to light than usual.
Today was not fun.
I was still eating my cucumber and celery for snacks at work and today I had some rhubarb. I don't really like rhubarb but I wanted to try something different.
The Candida Diet and Good Vegetables
Good candida yeast diet vegetables are alfalfa sprouts, asparagus, beets, bell peppers, brussel sprouts, all the cabbages are good for the candida diet including broccoli. Carrots are a very controversial food on the candida diet, I have seen one yeast infection diet say yes and the next say no. Now they are a simple sugar when digested, but they are also an antifungal and keep the yeast infection from spreading. I just had to go on what the Mycologists said on this one, which is to eat them, raw. If you cook carrots it raises the glycemic index to double that of a raw carrot.
Other good candida yeast diet vegetables are celery, dandelion greens, eggplant, fennel, garlic, kelp, all the lettuces, onion, pumpkin, kale, spinach, and all the squashes. Tomatoes, turnip greens, watercress, aloe vera, rhubarb, and yucca.
Entry for January 28, 2007
Eat your veggies!!!
Veggie Combo Can Stave Off Prostate Cancer
Thursday January 25, 2007
It's a diagnosis most men fear and about one in seven Canadian males will have to face at one point: prostate cancer. Diet can have a big impact on your health and a recent American study suggests that a combination of vegetables can help prevent the disease.
Broccoli and tomatoes have been proven to contain cancer-fighting agents separately, but scientists at the University of Illinois have found that when you eat them together they work even better at staving off the illness.
U of I doctoral candidate Kirstie Canene-Adams, the study's lead author, and two food science and human nutrition professors teamed up and fed a powdered mixture of tomato and broccoli to rats with prostate cancer.
Some of the rodents received only the tomato or broccoli alone, some got lycopene, the cancer fighting agent in tomatoes, and others were given a drug commonly prescribed to men with enlarged prostates. A group of rats was also castrated.
After 22 weeks researchers weighed the animals' tumours and found that the broccoli-tomato powder did the best job in curtailing tumour growth, after castration, which halts the production of the hormones that spur cancer growth.
While tomatoes and broccoli have been shown to slow the growth of cancer cells, doctors recommend that men try and eat a well-balanced diet, full of fruits and veggies of all varieties to help stave off disease.
"We've known for a long time that diet was a major factor in whether patients develop prostate cancer," said Dr. Laurence Klotz, a prostate cancer specialist at Sunnybrook Health Sciences Centre. "The diet that's healthy for your prostate is healthy for your heart."
If you're thinking about taking a supplement instead of the real thing you may want to think again. Researchers found that taking a substitute didn't work as well as eating the veggies.


text:
(Yicai Global) June 6 -- One of the world's biggest mobile phone markets -- the US -- is the sole remaining frontier for Huawei Technologies Co., the largest telecoms equipment maker, to conquer. Huawei's sales in the country account for about 4 percent of its total.
American consumers know little about the Huawei brand, negative or positive, said analysts at market consultancy group Current Analysis. "They do not even know how to pronounce the word 'Huawei.'"
But now, Huawei is determined to tell a Forrest Gump-like story to the world: it is just a matter of time before it opens the door to the US market.
Shenzhen-based Huawei aims to overtake Samsung Electronics Co. and Apple Inc. within the next five years to become the biggest smartphone maker, with a market share of more than 25 percent, Mr. Richard Yu, CEO of Huawei's consumer electronics business, said at the Converge technology conference co-hosted recently by The Wall Street Journal and f.ounders in Hong Kong.
"We want to be the number-one smartphone maker in the world," Mr. Yu said. "It's a long distance race, and we have the patience."
Following the launch of its Nexus 6P in the US in partnership with Google, Huawei said it seeks to keep improving performance in that market.
"Our growth is mainly coming from the high-end, premium segment," Mr. Yu said. "If you want to be the leading vendor you have to lead in the high-end."
Clearly, to lead in the high-end, a global handset manufacturer must crack the US market. Huawei plans this year to roll out new Honor series products, distributed mainly through e-commerce channels, in the US. On top of that, the Huawei MateBook, a 2-in-1 laptop developed by Huawei with Microsoft Corp. and Intel Corp., will soon be available for sale in the US. In addition to traditional sales channels, MateBook will also be sold at nearly 100 Microsoft flagship stores across the US.
Huawei is closing the gap with Samsung and Apple in the global smartphone market, where overall growth has been slowing. Huawei's smartphone sales have been growing fast not only in China but also in Europe, the Middle East and other parts of the world. It seems that conquering the US market is critical for the firm to win the overall battle.
In the first quarter, Huawei's smartphone sales volume jumped 59 percent from a year earlier, while Samsung's remained almost flat and Apple's shrank 14 percent, according to research firm Gartner Inc. Huawei's market share in the quarter rose to 8.3 percent, behind Apple's 15 percent and Samsung's 23 percent.
While increasing its market share, Huawei has also been focusing more on high-end products, such as its latest flagship phone, the P9, which features a dual-lens camera it developed in cooperation with German optics company Leica Camera AG.
Mr. Yu said that Huawei's partnership with Leica is exclusive and long-term. He expects the collaboration to continue for at least the next five years.
He also said that Huawei is pushing further into new technologies such as virtual reality. Based on its partnership with Alphabet Inc.'s Google, which provides a VR software platform, the company plans to release a new VR-compatible smartphone this fall, he said.


text:
7415 Ne Bay Cove Ct, Boca Raton, FL - $3,645,000
Stunning 5BR/4.5BA/3CG estate situated on an oversized corner lot w/135 ft of water frontage. Direct ocean access, no fixed bridges. Grand entrance w/2 dramatic fire urns. Exquisite glass wine room w/180 bottle capacity. Gourmet chef's kitchen w/custom cabinetry & quartzite counters/backsplash. Subzero/Wolf Appliances includes gas cooktop, double ovens, built-in coffee system, & 2 dishwashers. Open floor plan, 2 wet bars, 2 laundry rooms, floating staircase w/glass railing, 3-sided contemporary gas burning fireplace. 85 ft of sliding glass doors leads to the sprawling outdoor entertaining area. Resort style pool w/sun shelf & fire feature. Fully equipped summer kitchen, outdoor shower, & boat lift. Impact glass doors/windows, 2 driveways, whole house generator ready. Fully furnished!
Cable, 3-Phase Electric, Public Sewer, Public Water
Interior Canal, No Fixed Bridges, Seawall, Ocean Access
Walk-in Closet, Fireplace(s), Pantry, Bar, Built-in Shelves, Custom Mirror
Dishwasher, Disposal, Dryer, Microwave, Refrigerator, Washer, Water Heater - Gas, Auto Garage Open, Compactor, Range - Gas, Generator Hookup, Cooktop
Built-in Grill, Fence, Outdoor Shower, Open Balcony, Zoned Sprinkler, Custom Lighting, Summer Kitchen, Wrap-Around Balcony
1/4 to 1/2 Acre, Corner Lot, Sidewalks
J. C. Mitchell Elementary School
Boca Raton Community Middle School
Boca Raton Community High School
|Status Changed from Active to Contingent
|Status Changed from New to Active
All listings featuring the BMLS logo are provided by Beaches MLS Inc. Copyright 2019 Beaches MLS. This information is not verified for authenticity or accuracy and is not guaranteed.
© 2019 Beaches Multiple Listing Service, Inc. All rights reserved.
Listing information last updated on October 21st, 2019 at 9:00am EDT.


text: Release Time: 03:00 New York time (EST)Primary currency pair: EUR/NOK, USD/NOKForecast: ---Prior: 51.9LT1 (Lower Trigger 1): ---UT1 (Upper Trigger 1): ---Safety: 10There are not enough estimates this month to select the proper median estimate.There are only two estimates. The highest estimate is 50.8 (one estimate), and finally, the lowest estimate is 50.6 (one estimate). Perhaps you can use your own median, such as 50.7 but this might be too risky to trade. I would skip it this time.


text:
Go for it.
It's completely creepy and inappropriate, if you ask me.
Super pretty
He had time to lose interest in you. Yes, people lose interest when they had some before. He's not saying he finds you physically unattractive. He's saying he's not interested in you anymore.
A+ one of the best experiences
Till the next time mon chèrie.
If the genders were reversed, I wonder if opinions would shift.
Well, not everyone does. Such is life.
No? What now, Johan, my sensei?
Being "chivalrous" is not the golden key.
Hi.chat me up to know about me thank.
She is truely amazing.
These kinds of stories rarely have happy endings.
Hi..I am a white-haired guy over 75. Very active and in good shape. Enjoy life in Vegas. Don't gamble. Do go out for dinner and a show occasionally. Looking for a lady over 60, warm, witty, charming.
I am looking to find a serious relationship and to settle down with the.
By visiting this website, you agree that you are aged 18 or older. Aspurioustale.com only allows adult individuals to advertise their time and companionship to other adult individuals. We do not provide a booking service nor arrange meetings. Any price indicated relates to time only and nothing else. Any service offered or whatever else that may occur is the choice of consenting adults and a private matter between them. In some countries, individuals do not legally have the choice to decide this; it is your responsibility to comply with local laws.
#Foundation_Nylon » #Funniest_Orgasm » #Babysitter_Handjob » #Lol_Teen » #Menses_Porn » #Fisting_Pigmy » #Teen_Breeding » #Gav_Pissing » #Polyamide_Nylon » #Naomi_Brazzers » #Chunky_Nude » #Nylon_Density » #Vintage_Scenery » #Tired_Teen » #Softball_Tits » #Asian Blowjob Gif » #Ebony Pussy Squirt » #Hentai_Plus
Aspurioustale.com is a site of information and publicity and has no connection or link with any sites whatsoever or individuals mentioned here. We are only an advertising space, we are not an escort agency, nor even in the escorting or the business of prostitution. We take no responsibility for the content or actions of third parties (websites or individuals) on which you would have information such as emails or telephone contacts.
Home | Reviews | YoungPorn | Terms And Conditions | Contact Us | Sitemap


text:
The Garda Armed Support Unit was called to unrest in Ballyfermot this afternoon.
A number of young people were involved in what gardaí have described as a public order incident on Clifden Drive in Cherry Orchard at around 1 o'clock this afternoon.
Two men aged in their mid- 20s recieved serious but non- life threatening injuries.


text:
Way Fair Sheet Set Queen Size Leopard Print 100% Cotton 600 Thread-Count (15 Deep Pocket Drop) by Description
Size:Queen  | Color:Leopard Print Way Fair 100% Cotton. The 100% Egyptian cotton fabric is our perfect solution to luxurious and affordable bedding. The Cotton structure produces a soft, breathable weave that is stain and wrinkle resistant. The fully elasticized fitted sheet guarantees a secure fit on mattress depths up to 15 inches. Sheet set is machine washable and tumble dry. Long-lasting: stitched tailoring is more durable and well keeps your Sheet Fine texture and sophisticated sewing give you perfect using experience. Available Product: Sheet set, Duvet set, Fitted Sheet, Flat Sheet, Pillowcases, Comforter, Quilt cover, Crib fitted sheet Spinach Duvet set. Available Size – 28'X75′ Size. 30'X75′ Size 32'X75′ Size 42'X80′ Size 48'X75′ Size Twin Twin-XL Full Full-XL Queen Short Queen (60′ x 75′ Short Queen King RV King California King Short King etc. Solid/Stripe/Animal print Colors Available.
Way Fair Sheet Set Queen Size Leopard Print 100% Cotton 600 Thread-Count (15 Deep Pocket Drop) by how to buy
We provide soothing delivery, most of us sell solely certified solutions with a assurance of up to a few months and provide the kind of documentation. Often the delivery subject of Way Fair Sheet Set Queen Size Leopard Print 100% Cotton 600 Thread-Count (15 Deep Pocket Drop) by comforters absolutely all of countries around the world. We warranty delivery from the shortest possible time frame if the things are in all of our stock as well as manufacturer's factory.
We are good friends with companies and we like our consumers! Every week in the store you will discover new campaigns, unique together with beneficial delivers for you.
Will you surprise your buddies by replenishing your house having necessary as well as eye-pleasing stuff not leaving your home? Do searching in 2. - they have fast, simple and practical!